Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Diagnostics
MedTech
Boston Scientific hit by cyberattack
This year has seen a growing number of medtechs hit by cyberattacks, and now Boston Scientific has become the latest victim.
Ben Adams
Aug 26, 2026 7:26am
Labcorp launches new hepatitis D test
Aug 25, 2026 1:22pm
Qiagen appoints new chief executive after 9-month search
Aug 24, 2026 11:17am
Roche, Eli Lilly net FDA approval for Alzheimer’s biomarker test
Aug 24, 2026 8:15am
Craif raises $33M to boost work on its urine test for cancer
Aug 18, 2026 10:04am
FDA clears Lantheus’ Alzheimer’s PET imaging agent Tauklarify
Aug 17, 2026 7:51am
